Search

Search Constraints

You searched for: Author/Creator Ma, Yiyuan

Search Results

1. Efficacy, safety, and health-related quality of life from a global phase 3 study of tislelizumab as second- or third-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): RATIONALE 303. (March 2022)

2. Elucidating the Size‐Dependency of In Vitro Digested Polystyrene Microplastics on Human Intestinal Cells Health and Function. Issue 13 (11th February 2022)